Silo Pharma, Inc.
SILO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,906 | $3,524 | $11,367 | $9,837 |
| Short-Term Investments | $3,175 | $4,141 | $3 | $420 |
| Receivables | $0 | $0 | $66 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $31 | $16 | $136 | $145 |
| Total Curr. Assets | $7,111 | $7,681 | $11,572 | $10,402 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $241 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $61 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $59 | $65 | $71 | $27 |
| Total NC Assets | $300 | $65 | $71 | $88 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,412 | $7,746 | $11,643 | $10,490 |
| Liabilities | – | – | – | – |
| Payables | $1,584 | $703 | $364 | $418 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $72 | $72 | $72 | $72 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $1,656 | $776 | $436 | $490 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $722 | $794 | $866 | $938 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $722 | $794 | $866 | $938 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,378 | $1,569 | $1,302 | $1,428 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $10 |
| Retained Earnings | -$15,265 | -$10,872 | -$7,171 | -$3,263 |
| AOCI | $2 | -$6 | $0 | $0 |
| Other Equity | $20,296 | $17,055 | $17,512 | $12,315 |
| Total Equity | $5,034 | $6,177 | $10,341 | $9,062 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,412 | $7,746 | $11,643 | $10,490 |
| Net Debt | -$3,906 | -$3,524 | -$11,367 | -$9,837 |